Join us for a great evening covering diversity in clinical trials and harmonizing clinical research for participant protection.
We have 4 inspiring presenters.
- Alex Karabanow and Janice E. Parente, Human Research Accreditation Canada: Harmonizing Clinical Research through National Standards and Accreditation
- Pertice Moffitt, Manager, Health Research Programs at Aurora Research Institute: Indigenous perspective on inclusion in clinical trials
- Pandy Opima, Director, Study Leader Astra Zeneca, TransCelerate BioPharm Contributor: Sharing diversity tools
Learning Objectives:
- Understanding the challenges we face harmonizing clinical research in Canada.
- Discovering the current National Standards of Canada for human research.
- Discovering the accreditation program for human research in Canada and how it differs from the American model.
- Learning how accreditation based on the National Standards of Canada creates harmonized conduct and a trust framework among clinical research sites and research ethics boards.
- Understanding the existing solutions available from stakeholders focused on Diversity of Participants in Clinical Trials
- How to incorporate D&I considerations during the concept development phase
- Determine some potential ways sponsors can partner with sites to support the enrollment and retention of underrepresented minorities, as well as engage new sites to embed clinical trials in community practice settings that serve underrepresented patient populations
- How to form regulatory perspectives on the importance of proactive strategies, scientifically and clinically driven, to enhance meaningful representation of S adult patients from racially and ethnically diverse communities in clinical trials to better characterize the benefit-risk profile of medical products and if approved, generalize trial results in clinical practice
